


FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

FDA Clearance of Investigational New Drug for Patients with Krabbe Disease

United Leukodystrophy Foundation

RESKUE Trial for Patients with Krabbe Disease
